| Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer E Tran, S Turcotte, A Gros, PF Robbins, YC Lu, ME Dudley, ... Science 344 (6184), 641-645, 2014 | 2428 | 2014 |
| Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells L Gattinoni, XS Zhong, DC Palmer, Y Ji, CS Hinrichs, Z Yu, C Wrzesinski, ... Nature medicine 15 (7), 808-813, 2009 | 1082 | 2009 |
| Tumor-specific Th17-polarized cells eradicate large established melanoma P Muranski, A Boni, PA Antony, L Cassard, KR Irvine, A Kaiser, ... Blood, The Journal of the American Society of Hematology 112 (2), 362-373, 2008 | 1017 | 2008 |
| Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function R Zeng, R Spolski, SE Finkelstein, SK Oh, PE Kovanen, CS Hinrichs, ... The Journal of experimental medicine 201 (1), 139-148, 2005 | 865 | 2005 |
| Complete regression of metastatic cervical cancer after treatment with human papillomavirus–targeted tumor-infiltrating T cells S Stevanović, LM Draper, MM Langhan, TE Campbell, ML Kwong, ... Journal of Clinical Oncology 33 (14), 1543, 2015 | 798 | 2015 |
| Exploiting the curative potential of adoptive T‐cell therapy for cancer CS Hinrichs, SA Rosenberg Immunological reviews 257 (1), 56-71, 2014 | 690 | 2014 |
| Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling CM Paulos, C Wrzesinski, A Kaiser, CS Hinrichs, M Chieppa, L Cassard, ... The Journal of clinical investigation 117 (8), 2197-2204, 2007 | 608 | 2007 |
| IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy CS Hinrichs, R Spolski, CM Paulos, L Gattinoni, KW Kerstann, DC Palmer, ... Blood, The Journal of the American Society of Hematology 111 (11), 5326-5333, 2008 | 521 | 2008 |
| Reassessing target antigens for adoptive T-cell therapy CS Hinrichs, NP Restifo Nature biotechnology 31 (11), 999-1008, 2013 | 478 | 2013 |
| Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity CS Hinrichs, ZA Borman, L Cassard, L Gattinoni, R Spolski, Z Yu, ... Proceedings of the National Academy of Sciences 106 (41), 17469-17474, 2009 | 462 | 2009 |
| Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer S Stevanović, A Pasetto, SR Helman, JJ Gartner, TD Prickett, B Howie, ... Science 356 (6334), 200-205, 2017 | 376 | 2017 |
| Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy CS Hinrichs, ZA Borman, L Gattinoni, Z Yu, WR Burns, J Huang, ... Blood, The Journal of the American Society of Hematology 117 (3), 808-814, 2011 | 365 | 2011 |
| Determinants of Successful CD8+ T-Cell Adoptive Immunotherapy for Large Established Tumors in Mice CA Klebanoff, L Gattinoni, DC Palmer, P Muranski, Y Ji, CS Hinrichs, ... Clinical Cancer Research 17 (16), 5343-5352, 2011 | 323 | 2011 |
| Type 17 CD8+ T cells display enhanced antitumor immunity CS Hinrichs, A Kaiser, CM Paulos, L Cassard, L Sanchez-Perez, ... Blood, The Journal of the American Society of Hematology 114 (3), 596-599, 2009 | 263 | 2009 |
| A phase II study of tumor-infiltrating lymphocyte therapy for human papillomavirus–associated epithelial cancers S Stevanović, SR Helman, JR Wunderlich, MM Langhan, SL Doran, ... Clinical Cancer Research 25 (5), 1486-1493, 2019 | 224 | 2019 |
| Lymphedema secondary to postmastectomy radiation: incidence and risk factors CS Hinrichs, NL Watroba, H Rezaishiraz, W Giese, T Hurd, KA Fassl, ... Annals of surgical oncology 11, 573-580, 2004 | 223 | 2004 |
| Interleukin-2-dependent mechanisms of tolerance and immunity in vivo PA Antony, CM Paulos, M Ahmadzadeh, A Akpinarli, DC Palmer, N Sato, ... The Journal of Immunology 176 (9), 5255-5266, 2006 | 221 | 2006 |
| T-cell receptor gene therapy for human papillomavirus–associated epithelial cancers: a first-in-human, phase I/II study SL Doran, S Stevanović, S Adhikary, JJ Gartner, L Jia, MLM Kwong, ... Journal of Clinical Oncology 37 (30), 2759, 2019 | 207 | 2019 |
| TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers NB Nagarsheth, SM Norberg, AL Sinkoe, S Adhikary, TJ Meyer, JB Lack, ... Nature medicine 27 (3), 419-425, 2021 | 197 | 2021 |
| Targeting of HPV-16+ epithelial cancer cells by TCR gene engineered T cells directed against E6 LM Draper, MLM Kwong, A Gros, S Stevanović, E Tran, S Kerkar, ... Clinical Cancer Research 21 (19), 4431-4439, 2015 | 184 | 2015 |
